Placebo is identical in composition to empagliflozin but does not contain the iSGLT2 active substance. clinical trials

Effect of Empagliflozin in patients with eGFR between 10 and 20 ml/min/1.73m2 - EMPA [10-20]

This study is looking at a medicine called Jardiance for people with kidney problems and type 2 diabetes. We want to see if Jardiance helps reduce protein in the urine, which can be a sign of kidney damage. We also check other health markers and any side effects.